Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests
- PMID: 17072588
- DOI: 10.1007/s00213-006-0607-9
Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests
Abstract
Rationale: Premenstrual dysphoric disorder (PMDD) has been assumed to be a subtype of premenstrual syndrome (PMS) with depressive symptoms, such as depressive mood, tension, anxiety, and mood liability during luteal phase. At present, no conclusion has been established about serotonergic function in PMDD.
Objective: The purpose of this study was to investigate the serotonergic function of PMDD subjects in comparison to PMS without PMDD subjects and normal controls via neuroendocrine challenge tests.
Subjects and methods: Twenty-four women (seven with PMDD, eight with PMS without PMDD, and nine normal controls) were tested on three occasions (follicular phase, early luteal phase, and late luteal phase) receiving paroxetine 20 mg orally as a serotonergic probe at 8:00 A: .M: . Plasma ACTH and cortisol were measured prior to the administration and every hour for 6 h thereafter.
Results: As a whole, there were significant differences in serotonergic function measured by ACTH and cortisol responses to paroxetine challenge across these three groups. PMDD subjects showed higher serotonergic function in follicular phase but lower serotonergic function in luteal phase, compared with women with PMS without PMDD and normal controls.
Conclusion: The present findings suggest that PMDD women have fluctuating serotonergic function across their menstrual cycles and that the pattern may be different from PMS without PMDD.
Similar articles
-
Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).Horm Behav. 2008 Jun;54(1):185-93. doi: 10.1016/j.yhbeh.2008.02.018. Epub 2008 Mar 7. Horm Behav. 2008. PMID: 18413151 Free PMC article. Clinical Trial.
-
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.Cochrane Database Syst Rev. 2024 Aug 14;8(8):CD001396. doi: 10.1002/14651858.CD001396.pub4. Cochrane Database Syst Rev. 2024. PMID: 39140320 Review.
-
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.Psychoneuroendocrinology. 2001 Aug;26(6):551-64. doi: 10.1016/s0306-4530(01)00010-5. Psychoneuroendocrinology. 2001. PMID: 11403977 Clinical Trial.
-
Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.J Clin Psychiatry. 2008 Jun;69(6):991-8. doi: 10.4088/jcp.v69n0616. J Clin Psychiatry. 2008. PMID: 18517289 Clinical Trial.
-
Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. doi: 10.1089/jwh.2006.15.57. J Womens Health (Larchmt). 2006. PMID: 16417420 Review.
Cited by
-
Biological aspect of hyperthymic temperament: light, sleep, and serotonin.Psychopharmacology (Berl). 2011 Feb;213(2-3):633-8. doi: 10.1007/s00213-010-1999-0. Epub 2010 Aug 28. Psychopharmacology (Berl). 2011. PMID: 20802998
-
ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.J Clin Endocrinol Metab. 2012 Jun;97(6):1887-96. doi: 10.1210/jc.2011-3451. Epub 2012 Mar 30. J Clin Endocrinol Metab. 2012. PMID: 22466349 Free PMC article. Clinical Trial.
-
Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.Eur Arch Psychiatry Clin Neurosci. 2013 Dec;263(8):685-93. doi: 10.1007/s00406-013-0398-z. Epub 2013 Mar 2. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 23455589
-
Higher Circulating Cortisol in the Follicular vs. Luteal Phase of the Menstrual Cycle: A Meta-Analysis.Front Endocrinol (Lausanne). 2020 Jun 2;11:311. doi: 10.3389/fendo.2020.00311. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32582024 Free PMC article.
-
Premenstrual dysphoria and luteal stress in dominant-social-status female macaques.Evid Based Complement Alternat Med. 2013;2013:393862. doi: 10.1155/2013/393862. Epub 2013 Nov 28. Evid Based Complement Alternat Med. 2013. PMID: 24371458 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials